Inside the Clinical Diagnostics Industry: Constraints Shaping Strategy — Towards Health Intelligence
The foundational Persodia book examines diagnostics as a system governed by enduring structural constraints and provides the analytical framework from which Persodia Research was established.
Book Note
Published February 2026
Miguel Oliveira
Why does this matter now?
Diagnostics strategy is often discussed through products, technologies and individual company decisions.
Those perspectives matter, but they do not explain why similar strategic problems recur across different companies, categories and market cycles.
Inside the Clinical Diagnostics Industry: Constraints Shaping Strategy — Towards Health Intelligence identifies the structural conditions shaping what is operationally feasible, commercially durable and institutionally adoptable in clinical diagnostics.
Those conditions are becoming more important as the industry moves towards Health Intelligence: a model in which diagnostics becomes more connected, more evidence-intensive and more integrated into clinical and system-level decisions.
The central argument
The diagnostics industry is shaped less by managerial intention or product quality alone than by recurring structural conditions that define what is operationally feasible, commercially durable and institutionally adoptable.
Strategy that ignores these conditions repeatedly produces avoidable surprises.
Strategy built on them becomes more legible and more durable.
The structural framework
The book organises these conditions through four interacting structural layers.
Operational architecture
Infrastructure irreversibility
Clinical deployment depends on infrastructure choices that are difficult to reverse once embedded.
Capital embedding
Diagnostics businesses require capital to remain committed over extended timelines before returns become visible.
Company architecture
Regulated portfolio inertia
Regulated portfolios create strategic constraints that differ materially from those of more flexible technology markets.
Scale reconfiguration
Scale changes the operating logic of the business. It is not simply a matter of selling more units.
Market interface
Downstream mediation
Manufacturers do not control the full path between product capability and clinical use.
Partnership asymmetry
Partnerships often contain structural imbalances in information, capital, control and timing.
System environment
Market-access gatekeeping
Regulatory clearance is necessary but insufficient. Multiple institutional gates remain between availability and sustained use.
Evidence Escape
Evidence can exist without becoming authority. Its strategic value depends on whether it reaches the actors and decisions capable of changing practice.
Together, these eight constraints provide a structural model for interpreting recurring strategic patterns across the diagnostics industry.
Relation to Persodia Research
Persodia Research extends and applies the analytical framework developed in this book.
The IVD Industry Monograph series, Insights, Event Notes and future Persodia materials use this structural model to examine specific industrial questions, market observations and strategic implications in greater depth.
The book establishes the framework.
Persodia Research is where that work continues.
Strategic implications
Executives should assess strategy not only through the attractiveness of individual products or markets, but also through the structural conditions shaping deployment, scale, evidence, partnerships and capital commitment.
Investors should consider whether a company’s strategy is compatible with the industrial architecture of diagnostics rather than relying solely on technical differentiation or addressable-market estimates.
Laboratories and healthcare stakeholders should recognise that adoption depends on a broader system of institutional, operational and evidence conditions.
The framework does not replace company-specific analysis. It makes that analysis more legible.
Access
Inside the Clinical Diagnostics Industry: Constraints Shaping Strategy — Towards Health Intelligence is available through Amazon.